Post

India's Piramal invest in Berlin Germany R&D

India's Piramal invest in Berlin Germany R&D

Mumbai-based Piramal Enterprises is continuing research and development work in Berlin on the  PET (Positron Emission Tomography) technology it acquired from Bayer Healthcare earlier this year. The initiative wil lead to early detection of Alzheimer’s disease.

At a press briefing, Ajay Piramal, Chairman of the Piramal Group commented on the strategy, “Molecular imaging is one of the key technologies paving the way for individualized medicine. Our acquisition of a powerful pipeline in this field is an important milestone on the road to an innovative pharmaceutical portfolio.

Florbetaben, Piramal’s most advanced PET tracer, enables the detection of beta-amyloid deposits in the brain. “A phase III study to test the reliability of florbetaben in the histopathological detection of beta-amyloid has been successfully completed. Submission of the dossier for drug approval by the US Food and Drug Administration and the European Medicines Agency is expected later in 2012.

Share

About Amritt

Who We Are

Small or big, your business will love our financial help and business consultations! We are happy when our clients are too… Actually, this is quite simple to achieve – because each time we help them in sorting out different accounting intricacies or save the day before filing the taxes, they are happy indeed! And so are we.   

We have over Twenty years of experience helping our clients succeed in India
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Blog
Page
Dictionary
Comparisons
Capabilities
India Business Guide
Services
Private
Speaking
Insights
White Papers
News
Newsletters
Clients
Case Studies
Companies In India
Webinars
Presentations
Industries